Cargando…
Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease
The present review describes COVID-19 severity in diabetes and diabetic kidney disease. We discuss the crucial effect of COVID-19-associated cytokine storm and linked injuries and associated severe mesenchymal activation in tubular epithelial cells, endothelial cells, and macrophages that influence...
Autores principales: | Srivastava, Swayam Prakash, Srivastava, Rohit, Chand, Subhash, Goodwin, Julie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398861/ https://www.ncbi.nlm.nih.gov/pubmed/34451848 http://dx.doi.org/10.3390/ph14080751 |
Ejemplares similares
-
Editorial: Combating Diabetes and Diabetic Kidney Disease
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021) -
Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021) -
Cancer Biology and Prevention in Diabetes
por: Srivastava, Swayam Prakash, et al.
Publicado: (2020) -
Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms
por: Bhatia, Divya, et al.
Publicado: (2023) -
Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)